NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease

Archives of Medical Science

Volumn 10, Issue 4, 2014, Pages 791-800

  Wang, Lili ^a   Qu, Peng ^a   Zhao, Jian ^a   Chang, Yeting ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Coronary artery disease; Interleukin 18; Interleukin 1 ; NLRP3 inflammasome

Indexed keywords

CRYOPYRIN; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENSINI SCORE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84907463613     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.44871     Document Type: Article

References (32)

1. Libby P, Ridker PM. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43. (Pubitemid 34212626)
2. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6: 508-19. (Pubitemid 43980523)
3. Lundberg AM, Hansson GK. Innate immune signals in atherosclerosis. Clin Immunol 2010; 134: 5-24.
4. Hartvigsen K, Chou MY. The role of innate immunity in atherogenesis. J Lipid Res 2009; 50 Suppl: S388-93.
5. Akira S, Uematsu S. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801. (Pubitemid 43261452)
6. Cassel SL, Joly S. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 2009; 21: 194-8.
7. Tangi TN, Elmabsout AA. Role of NLRP3 and CARD8 in the regulation of TNF-alpha induced IL-1beta release in vascular smooth muscle cells. Int J Mol Med 2012; 30: 697-702.
8. Rajamaki K, Lappalainen J. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 2010; 5: e11765.
9. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606. (Pubitemid 13187192)
10. Davies JQ, Gordon S. Isolation and culture of human macrophages. Methods Mol Biol 2005; 290: 105-16.
11. Masters SL, Simon A. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 2009; 27: 621-68.
12. Ait-Oufella H, Taleb S. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 2011; 31: 969-79.
13. Ragino YI, Chernyavski AM. Activity of the inflammatory process in different types of unstable atherosclerotic plaques. Bull Exp Biol Med 2012; 153: 186-9.
14. Yu M, Wen N. Effect of repeated ischaemic preconditioning on TLR4 and proinflammatory cytokines TNF-alpha and IL-1beta in myocardial ischaemia-reperfusion injury in a rat model. Arch Med Sci 2010; 6: 843-7.
15. Jawień J, Olszanecki R. Apolipoprotein E knockout mice: an experimental model to study inflammatory mechanisms of atherosclerosis and to screen a putative anti-atherogenic properties of drugs. Centr Eur J Immunol 2012; 37: 36-44.
16. Göçmen AY, Gu S. Paraoxonase-1 activity and the levels of lipids and lipid peroxidation markers in arterial versus venous blood samples in coronary angiography patients. Postep Kardiol Inter 2012; 9: 199-204.
17. Dinarello CA. Anti-inflammatory agents: present and future. Cell 2010; 140: 935-50.
18. Bolormaa V, Yun HY. The NALP3/NLRP3 inflammasome instigates obesity-induced autoinflammation and insulin resistance. Nat Med 2011; 17: 179-88.
19. Jiang YG, Wang M. Oxidized low-density lipoprotein induces secretion of interleukin-1beta by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation. Biochem Biophys Res Commun 2012; 425: 121-6.
20. Connat JL. Inflammasome and cardiovascular diseases. Ann Cardiol Angiol 2011; 60: 48-54.
21. Duewell P, Kono H. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010; 464: 1357-61.
22. Menu P, Pellegrin M, Aubert JF, et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death and Disease 2011; 2: e137.
23. Zuurbier CJ, Jong WM. Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased IL-6/STAT3 signaling. PLoS One 2012; 7: e40643.
24. Pogorelov AG, Pogorelova VN. Electron probe microanalysis of potassium, sodium, and chlorine levels in the cardiomyocyte cytoplasm during acute ischemia. Biofizika 2010; 55: 875-9.
25. Schorn C, Frey B. Sodium overload and water influx activate the NALP3 inflammasome. J Biol Chem 2011; 286: 35-41.
26. Petrili V, Papin S. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 2007; 14: 1583-9. (Pubitemid 47278844)
27. Vanden Hoek TL, Becker LB. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning incardiomyocytes. J Biol Chem 1998; 273: 18092-8. (Pubitemid 28334725)
28. Sun HY, Wang NP. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 2005; 288: H1900-8.
29. Rubartelli A. Redox control of NLRP3 inflammasome activation in health and disease. J Leukoc Biol 2012; 92: 951-8.
30. Zhou R, Yazdi AS. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-5.
31. Segovia J, Sabbah A. TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One 2012; 7: e29695.
32. Jin C, Frayssinet P. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. Proc Natl Acad Sci U S A 2011; 108: 14867-72.